Qiagen N.V.
QIA | F
Overview
Corporate Details
- ISIN(s):
- DE000A286LP0 (+4 more)
- LEI:
- 54930036WK3GMCN17Z57
- Country:
- Netherlands
- Address:
- HULSTERWEG 82, 5912 PL VENLO
- Website:
- https://www.qiagen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Qiagen N.V. is a leading global provider of integrated "Sample to Insight" solutions designed to enable customers to gain valuable molecular insights from biological samples. The company's comprehensive portfolio covers the entire molecular testing workflow, from sample preparation technologies that isolate DNA, RNA, and proteins, to assay technologies and automated instrumentation for analysis. Qiagen also provides bioinformatics software to interpret the resulting data. Its products are utilized by a diverse customer base across molecular diagnostics, academic research, pharmaceutical development, and applied testing, facilitating advancements in life sciences and clinical healthcare.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Qiagen N.V..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-13 00:00 |
Foreign Filer Report
Q1 statement / Q1 financial report 2025
|
English | 693.8 KB | |
| 2025-05-07 14:35 |
Notice of Dividend Amount
QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for sharehold…
|
English | 6.8 KB | |
| 2025-04-28 16:33 |
Annual Report (ESEF)
Qiagen N.V., Jaarlijkse financiële verslaggeving
|
English | 23.4 MB | |
| 2025-04-06 18:20 |
Earnings Release
QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates fu…
|
English | 7.2 KB | |
| 2025-03-31 00:00 |
Annual Report
Annual financial report 2024
|
English | 6.2 MB | |
| 2025-02-06 06:31 |
Earnings Release
QIAGEN delivers solid Q4 2024 growth ahead of outlook
|
English | 478.9 KB | |
| 2025-01-13 18:55 |
Transaction in Own Shares
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders throug…
|
English | 7.7 KB | |
| 2025-01-12 18:55 |
Share Issue/Capital Change
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders throug…
|
English | 7.7 KB | |
| 2024-11-07 07:30 |
Earnings Release
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024…
|
English | 421.6 KB | |
| 2024-09-03 09:01 |
Capital/Financing Update
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
|
English | 56.8 KB | |
| 2024-09-03 09:01 |
Capital/Financing Update
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
|
English | 44.5 KB | |
| 2024-08-16 15:34 |
Interim Report
|
English | 565.7 KB | |
| 2024-08-01 07:13 |
Earnings Release
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
|
English | 463.7 KB | |
| 2024-04-30 07:33 |
Earnings Release
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-y…
|
English | 384.1 KB | |
| 2024-04-26 18:20 |
Annual Report (ESEF)
|
English | 10.4 MB |
Automate Your Workflow. Get a real-time feed of all Qiagen N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Qiagen N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2017-02-15 | R. Sackers | Non-Executive member | Other | 61,499 | N/A |
| 2017-01-25 | R. Sackers | Non-Executive member | Other | 742 | N/A |
| 2016-12-16 | R. Sackers | Non-Executive member | Other | 23,419 | N/A |
| 2016-12-01 | R. Sackers | Non-Executive member | Sell | 9,729 | 265,375.40 USD |
| 2016-11-30 | R. Sackers | Non-Executive member | Other | 9,729 | N/A |
| 2016-10-31 | R. Sackers | Non-Executive member | Other | 144,809 | N/A |
| 2016-05-31 | R. Sackers | Non-Executive member | Other | 8,884 | N/A |
| 2016-03-07 | R. Sackers | Executive member | Sell | 57,128 | 1,257,903.15 USD |
| 2016-02-29 | R. Sackers | Non-Executive member | Sell | 60,890 | 1,295,614.38 USD |
| 2016-02-29 | M. Colpan | Non-Executive member | Sell | 3,340 | 71,578.04 USD |
